Basal cell carcinoma (BCC) is a rare tumor of the vulva because BCC is frequently seen in skin sites exposed to sun. Vulvar basal cell carcinoma accounts for < 1% of all BCCs and 2-5% of all vulvar carcinomas. The standard treatment for vulvar BCC is surgical excision and it produces good survival outcomes. This is a case report of an 83 year-old female who presented with a vulvar nodule associated with pruritus and bleeding. Initial vulvar biopsy revealed squamous cell carcinoma (SCCA). Patient underwent concurrent chemoradiation therapy for a Stage IIIB disease. Radical vulvectomy was subsequently done for tumor persistence. Surprisingly, the histopathology report of the persistent vulvar nodule revealed pigmented nodular basal cell carcinoma with lymphovascular invasion (LVSI). Patient was advised postoperative systemic chemotherapy but patient and relatives did not consent for the systemic treatment. Patient had no evidence of disease at 8 months post-surgery.
Carcinoma, Basal Cell